PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC: Form 990, tax year 2022
View the entire original 990 at ProPublica ↗
- Organization
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND INC (EIN 52-6063009)
- Tax period
- 2022-01-01 to 2022-12-31
- Filed
- 2023-07-12
- IRS object ID
- 202301939349300405
- Schema version
- 2022v5.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2023-07-12T06:32:49-05:00 | ReturnTs |
| Tax Period End | 2022-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | BDO USA PA | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 8401 GREENSBORO DRIVE 800 | AddressLine1Txt |
| City | MCLEAN | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22102 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2022-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 526063009 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PHARMACEUTICAL RESEARCH AND | BusinessNameLine1Txt |
| Business Name Line2 | MANUFACTURERS OF AMERICA FDN INC | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % TRACEY MERCHANT | InCareOfNm |
| Business Name Control | PHAR | BusinessNameControlTxt |
| Phone | 2025727755 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 950 F STREET Suite 300 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20004 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | AMY MILLER | PersonNm |
| Person Title | PRESIDENT | PersonTitleTxt |
| Phone | 2025727755 | PhoneNum |
| Signature | 2023-07-10 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | AMY | PersonFirstNm |
| Person Last | MILLER | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | XXX-XX-XXXX | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Marc Berger | PreparerPersonNm |
| PTIN | P01871563 | PTIN |
| Phone | 7038930600 | PhoneNum |
Additional Filer Information AdditionalFilerInformation
Trusted Customer TrustedCustomerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Trusted Customer | 2 | TrustedCustomerCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2022 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | AMY MILLER | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 950 F STREET300 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $5,432,782 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.PHRMAFOUNDATION.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1965 | FormationYr |
| Legal Domicile State | DC | LegalDomicileStateCd |
| Activity Or Mission | SEE SCHEDULE O | ActivityOrMissionDesc |
| Voting Members Governing Body | 10 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 10 | VotingMembersIndependentCnt |
| Total Employee | 3 | TotalEmployeeCnt |
| Total Volunteers | 86 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $2,764,822 | PYContributionsGrantsAmt |
| CY Contributions Grants | $3,535,607 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $928,344 | PYInvestmentIncomeAmt |
| CY Investment Income | $367,035 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $3,693,166 | PYTotalRevenueAmt |
| CY Total Revenue | $3,902,642 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $2,955,757 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $2,649,027 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $806,627 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $910,758 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $3,433 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $596,039 | PYOtherExpensesAmt |
| CY Other Expenses | $518,206 | CYOtherExpensesAmt |
| PY Total Expenses | $4,358,423 | PYTotalExpensesAmt |
| CY Total Expenses | $4,077,991 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$665,257 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$175,349 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $26,230,760 | TotalAssetsBOYAmt |
| Total Assets EOY | $22,787,225 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $172,489 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $1,467,134 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $26,058,271 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $21,320,091 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE PHRMA FOUNDATION WORKS TO IMPROVE PUBLIC HEALTH BY PROACTIVELY INVESTING IN INNOVATIVE RESEARCH, EDUCATION AND VALUE-DRIVEN HEALTH CARE. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | Yes (true) | SignificantChangeInd |
| Expense | $775,815 | ExpenseAmt |
| Grant | $620,835 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | DRUG DISCOVERY - THE PROGRAM CONSIDERS THE PROCESS THROUGH WHICH POTENTIAL NEW MEDICINES ARE IDENTIFIED. THE EVOLVING PROCESS OF DRUG DISCOVERY SHOULD INCLUDE INNOVATIVE CULTURE-BASED AND ANIMAL-BASED EFFORTS THAT EMBRACE NEW CUTTING-EDGE TECHNOLOGY. THE AWARDS PROVIDE STIPEND SUPPORT FOR INDIVIDUALS ENGAGED IN A MULTIDISCIPLINARY RESEARCH TRAINING PROGRAM THAT WILL CREATE FOR EXTEND THEIR CREDENTIALS AND PROVIDE NEW SKILLS. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $690,499 | ExpenseAmt |
| Grant | $497,764 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | VALUE ASSESSMENT - INITIATIVE TO DEVELOP STRATEGIES TO BETTER ASSESS THE VALUE OF MEDICINES AND HEALTH CARE SERVICES WHILE IMPROVING PATIENT OUTCOMES AND REDUCING INEFFICIENCY IN HEALTH CARE. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $627,456 | ExpenseAmt |
| Grant | $506,250 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | DRUG DELIVERY - THE PROGRAM EMPHASIZES THE QUANTITATIVE UNDERSTANDING AND USE OF THE PRINCIPLES UNDERLYING DRUG TRANSPORT, ROUTE OF ADMINISTRATION, FORMULATION COMPOSITION, TECHNOLOGY DEVELOPMENT AND MANUFACTURING/ENGINEERING ASPECTS INTENDED TO IMPROVE DRUG PRODUCT SAFETY AND EFFICACY, INCLUDING PATIENT COMPLIANCE. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $1,496,189 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $1,024,178 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $0 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $3,589,959 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | false | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | false | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (true) | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | false | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 19 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 3 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 10 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 10 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | TRACEY MERCHANT | PersonNm |
| Phone | 2025727755 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 950 F STREET NO 300 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (15 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd |
|---|---|---|---|---|---|---|---|---|
| AMY MILLER | ||||||||
| PRESIDENT | 37.5 | 0.0 | Yes (X) | $367,542 | $0 | $67,332 | ||
| JOANNE WESTPHAL | ||||||||
| DIRECTOR | 37.5 | 0.0 | $163,455 | $0 | $35,816 | Yes (X) | ||
| EMILY ORTMAN | ||||||||
| SENIOR DIRECTOR | 37.5 | 0.0 | $106,642 | $0 | $35,294 | Yes (X) | ||
| ANDREW PLUMP MD PHD | ||||||||
| CHAIRMAN | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| IRIS LOEW-FRIEDRICH MD | ||||||||
| Treasurer | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| GEORGE ADDONA PHD | ||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| MICHAEL DOLSTEN MD PHD | ||||||||
| DIRECTOR (THRU 10/2022) | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| AIDA HABTEZION MD MSC FRCPC | ||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| ARAN MAREE MB BCH MRCPI | ||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| FIONA H MARSHAL PHD | ||||||||
| DIRECTOR (THRU 9/2022) | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| MAHA RADHAKRISHNAN MD | ||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| JOHN C REED MD PHD | ||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| DANIEL SKOVRONSKY MD PHD | ||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| RUPERT VESSEY MA BM BCH | ||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| LORI REILLY ESQ | ||||||||
| EX OFFICIO MEMBER | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $637,639 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $138,442 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 3 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (2 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| O'Connor Consulting Services LLC | |||||
| 6507 Marjory Lane | BETHESDA | MD | 20817 | ACCOUNTING SERVICES | $112,675 |
| Reservoir Communications Group LLC | |||||
| 607 14th Street NW Suite 675 | WASHINGTON | DC | 20005 | CONSULTING | $120,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 2 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $3,535,607 | AllOtherContributionsAmt |
| Total Contributions | $3,535,607 | TotalContributionsAmt |
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $460,897 | TotalRevenueColumnAmt |
| Exclusion | $460,897 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,436,279 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,530,140 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$93,861 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$93,862 | TotalRevenueColumnAmt |
| Exclusion | -$93,862 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Fundraising Direct Expenses | $0 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $0 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,902,642 | TotalRevenueColumnAmt |
| Exclusion | $367,035 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $59,250 | TotalAmt |
| Program Services | $59,250 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,589,777 | TotalAmt |
| Program Services | $2,589,777 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $434,874 | TotalAmt |
| Program Services | $306,303 | ProgramServicesAmt |
| Management And General | $128,571 | ManagementAndGeneralAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $334,365 | TotalAmt |
| Program Services | $235,509 | ProgramServicesAmt |
| Management And General | $98,856 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $52,886 | TotalAmt |
| Program Services | $37,250 | ProgramServicesAmt |
| Management And General | $15,636 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $52,017 | TotalAmt |
| Program Services | $36,638 | ProgramServicesAmt |
| Management And General | $15,379 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $36,616 | TotalAmt |
| Program Services | $25,790 | ProgramServicesAmt |
| Management And General | $10,826 | ManagementAndGeneralAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,274 | TotalAmt |
| Management And General | $1,274 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $145,295 | TotalAmt |
| Management And General | $145,295 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,342 | TotalAmt |
| Management And General | $21,342 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $227,692 | TotalAmt |
| Program Services | $210,588 | ProgramServicesAmt |
| Management And General | $17,104 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $16,505 | TotalAmt |
| Program Services | $14,455 | ProgramServicesAmt |
| Management And General | $2,050 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,681 | TotalAmt |
| Program Services | $1,315 | ProgramServicesAmt |
| Management And General | $366 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $61,362 | TotalAmt |
| Program Services | $46,920 | ProgramServicesAmt |
| Management And General | $14,442 | ManagementAndGeneralAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,702 | TotalAmt |
| Program Services | $9,872 | ProgramServicesAmt |
| Management And General | $2,830 | ManagementAndGeneralAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $10,122 | TotalAmt |
| Program Services | $10,122 | ProgramServicesAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,760 | TotalAmt |
| Program Services | $6,170 | ProgramServicesAmt |
| Management And General | $2,590 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (2 entries)
| DescDesc | TotalTotalAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|
| BANK/PAYROLL CHARGES | $7,759 | $7,759 | $0 |
| DUES/PUBLICATIONS/PROJECTS | $3,712 | $279 | $3,433 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,077,991 | TotalAmt |
| Program Services | $3,589,959 | ProgramServicesAmt |
| Management And General | $484,599 | ManagementAndGeneralAmt |
| Fundraising | $3,433 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $922,819 | BOYAmt |
| EOY | $2,182,721 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $386 | BOYAmt |
| EOY | $0 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,676 | BOYAmt |
| EOY | $31,531 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $27,150 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $27,150 | LandBldgEquipAccumDeprecAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $25,288,879 | BOYAmt |
| EOY | $20,572,973 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,230,760 | BOYAmt |
| EOY | $22,787,225 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $153,182 | BOYAmt |
| EOY | $1,421,900 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $19,307 | BOYAmt |
| EOY | $45,234 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $172,489 | BOYAmt |
| EOY | $1,467,134 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,058,271 | BOYAmt |
| EOY | $21,320,091 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,058,271 | BOYAmt |
| EOY | $21,320,091 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $26,230,760 | BOYAmt |
| EOY | $22,787,225 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$175,349 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$4,582,942 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $20,111 | OtherChangesInNetAssetsAmt |
| Info In Schedule O Part XII | Yes (X) | InfoInScheduleOPartXIIInd |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,420,500 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $2,940,620 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,937,859 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,764,822 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $3,535,607 | CurrentTaxYearAmt |
| Total | $16,599,408 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $3,420,500 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $2,940,620 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,937,859 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,764,822 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $3,535,607 | CurrentTaxYearAmt |
| Total | $16,599,408 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $10,394,438 | SubstantialContributorsTotAmt |
| Public Support Total170 | $6,204,970 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $540,583 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $578,459 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $477,282 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $407,496 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $460,897 | CurrentTaxYearAmt |
| Total | $2,464,717 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $75,259 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $144,775 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $0 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $0 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $0 | CurrentTaxYearAmt |
| Total | $220,034 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $19,284,159 | TotalSupportAmt |
| Public Support CY170 | 0.32177 | PublicSupportCY170Pct |
| Public Support PY170 | 0.32563 | PublicSupportPY170Pct |
| Ten Pct Facts Crcmstncs Test CY | Yes (X) | TenPctFactsCrcmstncsTestCYInd |
| Facts And Circumstances Test | PART II, SECTION C, LINE 17A, FACTS AND CIRCUMSTANCES TEST: DURING 2022, THE ORGANIZATION CONTINUED TO TAKE MEASURES TO INCREASE ITS PUBLIC SUPPORT PERCENTAGE. THE ORGANIZATION CONCENTRATED EFFORTS ON CHAMPIONING ITS NEW, PATIENT-FOCUSED MISSION AND CONDUCING PATIENT-FOCUSED PROGRAMING TO ATTRACT NEW DONORS. ADDITIONALLY, MANAGEMENT HEALD A SERIES OF CALLS AND MEETINGS WITH POTENTIAL NEW SUPPORTERS THROUGHOUT THE YEAR. THE ORGANIZATION EXPANDED OFFERINGS TO PROVIDE EDUCATION TO THE GENERAL PUBLIC BY DEVELOPING A PUBLICLY AVAILABLE WEBINAR SERIES ON WRITING, CAREER PATHS, AND HOW TO APPLY FOR FEDERAL AND FOUNDATION GRANTS. THE ORGANIZATION'S BOARD OF DIRECTORS CONSISTS OF RESEARCH AND DEVELOPMENT EXECUTIVES AND CHIEF MEDICAL OFFICERS, ALL OF WHOM HAVE SPECIALIZED KNOWLEDGE AND EXPERTISE IN THE FIELD OF PHARMACEUTICAL RESEARCH AND VALUE ASSESSMENT AND HEALTH OUTCOMES RESEARCH. | FactsAndCircumstancesTestTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| CY Minus3 Yr Endwmt Fund | CYMinus3YrEndwmtFundGrp | |
| CY Minus4 Yr Endwmt Fund | CYMinus4YrEndwmtFundGrp | |
| Land | LandGrp | |
| Buildings | BuildingsGrp | |
| Leasehold Improvements | LeaseholdImprovementsGrp | |
| Equipment | EquipmentGrp |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $27,150 | OtherCostOrOtherBasisAmt |
| Depreciation | $27,150 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $0 | TotalBookValueLandBuildingsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | INTERCOMPANY SETTLEMENT | Desc |
| Amt | $45,234 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $45,234 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | -$610,931 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$4,582,942 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $70,600 | DonatedServicesAndUseFcltsAmt |
| Other Revenue | $20,111 | OtherRevenueAmt |
| Revenue Not Reported | -$4,492,231 | RevenueNotReportedAmt |
| Revenue Subtotal | $3,881,300 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $21,342 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $21,342 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $3,902,642 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $4,127,249 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $70,600 | DonatedServicesUseFcltsAmt |
| Expenses Not Reported | $70,600 | ExpensesNotReportedAmt |
| Expenses Subtotal | $4,056,649 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $21,342 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $21,342 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $4,077,991 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE D, PART X, LINE 2: | MANAGEMENT HAS EVALUATED THE FOUNDATION'S TAX POSITIONS AND CONCLUDED THAT THE FOUNDATION HAS NOT TAKEN ANY UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS. AT A MINIMUM, THE TAX PERIODS ENDED DECEMBER 31, 2019 AND LATER ARE OPEN FOR EXAMINATION BY TAXING AUTHORITIES. |
| SCHEDULE D, PART XI, LINE 2D: | GRANT REFUNDS $20,111 |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (6 entries)
| Address Line1USAddress/AddressLine1Txt | Address Line2USAddress/AddressLine2Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| American FDN for Pharmaceutical EduCATION | ||||||||
| 11325 Random Hills Road | SUITE 360A-105 | Fairfax | VA | 22030 | 530214882 | 501(C)(3) | $11,000 | AFPE PRE DOCTORAL FELLOWSHIP |
| A & J CONSULTING - MARYLAND LLC | ||||||||
| 313 S Collington Ave | Baltimore | MD | 21231 | 465318329 | $7,500 | VACA Challenge Award | ||
| The Tower Foundation of San Jose State University | ||||||||
| One Washington Sq | San Jose | CA | 951920183 | 830403915 | 501(C)(3) | $7,500 | VACA Challenge Award | |
| Sick Cells | ||||||||
| 1042 Maple Ave Suite 103 | Lisle | IL | 60532 | 813481633 | 501(c)(3) | $7,500 | VACA Challenge Award | |
| Oregon Health and Science University | ||||||||
| PO Box 3003 | Portland | OR | 972083003 | 931176109 | Govt Agency | $7,500 | VACA Challenge Award | |
| Thomas Jefferson University | ||||||||
| 1101 Market Street | Philadelphia | PA | 19107 | 231352651 | 501(C)(3) | $7,500 | VACA Challenge Award | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 5 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (8 entries)
| Grant TypeGrantTypeTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt |
|---|---|---|
| Pharmacology & Toxicology | 3 | $50,000 |
| Pharmaceuticals | 1 | $2,948 |
| Health Outcomes | 16 | $502,980 |
| Informatics | 3 | $31,250 |
| Translational Medicine | 9 | $420,000 |
| Value Assessment | 7 | $455,514 |
| Drug Delivery | 12 | $506,250 |
| Drug Discovery | 18 | $620,835 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE I, PART I, LINE 2: | THE GRANTS AND FELLOWSHIPS ARE AWARDED WITH INFORMATION ON HOW THE FUNDS MAY BE SPENT AND ADMINISTERED. THE SECOND YEAR OF FUNDING, IF APPLICABLE, IS CONTINGENT UPON A SATISFACTORY REVIEW OF THE AWARD RECIPIENT'S PROGRESS DURING THE FIRST TEN MONTHS OF FUNDING. A PROGRESS REPORT IS DUE TO THE FOUNDATION PRIOR TO THE BEGINNING OF THE SECOND YEAR OF FUNDING. THE PROGRESS IS ASSESSED BY THE ADVISORY COMMITTEE. THE DECISION TO CONTINUE THE FUNDING IS BASED ON ADHERENCE TO THE GOALS OF THE ANNOUNCEMENT OF THE OVERALL PROGRAM, AND ALSO IN KEEPING WITH THE ORIGINALLY PROPOSED RESEARCH ON WHICH THE AWARD WAS BASED. IN ADDITION TO THE PROGRESS REPORT, THE FOUNDATION MUST RECEIVE CERTIFICATION FROM THE THESIS ADVISOR THAT SATISFACTORY PROGRESS IS BEING ACHIEVED IF IT IS THE PRE DOCTORAL FELLOWSHIP. A FINANCIAL REPORT IS ALSO DUE TO THE FOUNDATION AFTER THE FIRST YEAR OF FUNDING AND FOLLOWING THE END OF THE FUNDING PERIOD FOR ALL AWARDS. THE INSTITUTION MUST STIPULATE THE AMOUNT OF FUNDS RECEIVED BY THE UNIVERSITY, HOW THE FUNDS HAVE BEEN USED/SPENT AND IF THERE IS A REMAINING BALANCE ON THE ACCOUNT. |
| SCHEDULE I, PART III: | CLINICAL PHARMACOLOGY AWARDS-THE INTENT OF THESE PROGRAMS IS TO GENERATE INTEREST IN RESEARCH CAREERS IN PHARMACOLOGY, INCLUDING CLINICAL PHARMACOLOGY, AMONG MEDICAL AND DENTAL STUDENTS BY SUPPORTING FELLOWSHIPS. PHARMACOLOGY/TOXICOLOGY AWARDS SUPPORT CAREER DEVELOPMENT ACTIVITIES OF SCIENTISTS PREPARED TO ENGAGE IN RESEARCH THAT INTEGRATES INFORMATION ON MOLECULAR OR CELLULAR MECHANISMS OF ACTION WITH INFORMATION ON THE EFFECTS OF AN AGENT OBSERVED IN AN INTACT ORGANISM. PHARMACEUTICS AWARDS SUPPORT YOUNG SCIENTISTS WITH STIPEND AND RESEARCH SUPPORT. PHARMACEUTICS IS THAT AREA OF BIOMEDICAL AND PHARMACEUTICAL SCIENCES THAT DEALS WITH DRUG DELIVERY SYSTEMS, IN PARTICULAR THE DESIGN AND EVALUATION OF CONTEMPORARY SYSTEMS, IN PARTICULAR THE DESIGN AND EVALUATION OF CONTEMPORARY PHARMACEUTICAL DOSAGE FORMS SO THAT THEY ARE SAFE, EFFECTIVE, AND RELIABLE. HEALTH OUTCOMES-OUTCOMES RESEARCH SPANS A BROAD SPECTRUM OF ISSUES FROM STUDIES EVALUATING THE EFFECTIVENESS OF A PARTICULAR PHARMACEUTICAL INTERVENTION TO THE IMPACT OF REIMBURSEMENT. THIS PROGRAM SUPPORTS YOUNG SCIENTISTS WITH STIPEND AND RESEARCH SUPPORT. INFORMATICS-THE GOAL IS TO PROMOTE THE USE AND DEVELOPMENT OF INFORMATICS IN AN INTEGRATIVE APPROACH TOWARDS THE UNDERSTANDING OF HUMAN BIOLOGICAL AND DISEASE. THIS PROGRAM SUPPORTS YOUNG SCIENTISTS WITH STIPEND AND RESEARCH SUPPORT. TRANSLATIONAL MEDICINE IS A DISCIPLINE FOCUSED ON BRIDGING EXPERIMENTAL AND COMPUTATIONAL TECHNOLOGIES AND DISCOVERIES IN THE RESEARCH LABORATORY TO THEIR APPLICATION IN CLINICAL PRACTICE. THESE AWARDS WILL ADVANCE TRAINING AND SUPPORT CAREER DEVELOPMENT OF SCIENTISTS ENGAGED IN RESEARCH THAT SIGNIFICANTLY INTEGRATES CUTTING-EDGE TECHNOLOGIES WITH ADVANCED BIOLOGICAL, CHEMICAL, AND PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FND, INC. 52-6063009 PHARMACOLOGICAL SCIENCES AND ENGINEERING METHODOLOGIES. VALUE ASSESSMENT - INITIATIVE TO DEVELOP STRATEGIES TO BETTER ASSESS THE VALUE OF MEDICINES AND HEALTH CARE SERVICES WHILE IMPROVING PATIENT OUTCOMES AND REDUCING INEFFICIENCY IN HEALTH CARE. DRUG DELIVERY - THE PROGRAM EMPHASIZES THE QUANTITATIVE UNDERSTANDING AND USE OF THE PRINCIPLES UNDERLYING DRUG TRANSPORT, ROUTE OF ADMINISTRATION, FORMULATION COMPOSITION, TECHNOLOGY DEVELOPMENT AND MANUFACTURING/ENGINEERING ASPECTS INTENDED TO IMPROVE DRUG PRODUCT SAFETY AND EFFICACY, INCLUDING PATIENT COMPLIANCE. DRUG DISCOVERY - THE PROGRAM CONSIDERS THE PROCESS THROUGH WHICH POTENTIAL NEW MEDICINES ARE IDENTIFIED. THE EVOLVING PROCESS OF DRUG DISCOVERY SHOULD INCLUDE INNOVATIVE CULTURE-BASED AND ANIMAL-BASED EFFORTS THAT EMBRACE NEW CUTTING-EDGE TECHNOLOGY. THE AWARDS PROVIDE STIPEND SUPPORT FOR INDIVIDUALS ENGAGED IN A MULTIDISCIPLINARY RESEARCH TRAINING PROGRAM THAT WILL CREATE FOR EXTEND THEIR CREDENTIALS AND PROVIDE NEW SKILLS. |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (2 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMY MILLER | ||||||||||||||
| PRESIDENT | $329,399 | $0 | $36,373 | $0 | $1,770 | $0 | $30,500 | $0 | $36,832 | $0 | $434,874 | $0 | $0 | $0 |
| JOANNE WESTPHAL | ||||||||||||||
| DIRECTOR | $141,138 | $0 | $19,558 | $0 | $2,759 | $0 | $16,715 | $0 | $19,101 | $0 | $199,271 | $0 | $0 | $0 |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (10 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART I, LINE 1: | DESCRIPTION OF ORGANIZATION MISSION THE PHRMA FOUNDATION WORKS TO IMPROVE PUBLIC HEALTH BY PROACTIVELY INVESTING IN INNOVATIVE RESEARCH, EDUCATION AND VALUE-DRIVEN HEALTH CARE. |
| FORM 990, PART III, LINE 3: | CLINICAL PHARMACOLOGY PROGRAM ENDED; 2021 WAS FINAL YEAR OF AWARDS PAYOUT FOR THIS PROGRAM. |
| FORM 990, PART III, LINE 4D: | OTHER PROGRAM SERVICES HEALTH OUTCOMES - OUTCOMES RESEARCH SPANS A BROAD SPECTRUM OF ISSUES FROM STUDIES EVALUATING THE EFFECTIVENESS OF A PARTICULAR PHARMACEUTICAL INTERVENTION TO THE IMPACT OF REIMBURSEMENT. THIS PROGRAM SUPPORTS YOUNG SCIENTISTS WITH STIPEND AND RESEARCH SUPPORT. EXPENSES $ 621,029. GRANTS $ 502,980. REVENUE $ 0. TRANSLATION MEDICINE IS A DISCIPLINE FOCUSED ON BRIDGING EXPERIMENTAL AND COMPUTATIONAL TECHNOLOGIES AND DISCOVERIES IN THE RESEARCH LABORATORY TO THEIR APPLICATION IN CLINICAL PRACTICE. THESE AWARDS WILL ADVANCE TRAINING AND SUPPORT CAREER DEVELOPMENT OF SCIENTISTS ENGAGED IN RESEARCH THAT SIGNIFICANTLY INTEGRATES CUTTING-EDGE TECHNOLOGIES WITH ADVANCED BIOLOGICAL, CHEMICAL, AND PHARMACOLOGICAL SCIENCES AND ENGINEERING METHODOLOGIES. EXPENSES $ 524,893. GRANTS $ 425,000. REVENUE $ 0. PHARMACEUTICS AWARDS SUPPORT YOUNG SCIENTISTS WITH STIPEND AND RESEARCH SUPPORT. PHARMACEUTICS IS THAT AREA OF BIOMEDICAL AND PHARMACEUTICAL SCIENCES THAT DEALS WITH DRUG DELIVERY SYSTEMS, IN PARTICULAR THE DESIGN AND EVALUATION OF CONTEMPORARY SYSTEMS, IN PARTICULAR THE DESIGN AND EVALUATION OF CONTEMPORARY PHARMACEUTICAL DOSAGE FORMS SO THAT THEY ARE SAFE, EFFECTIVE, AND RELIABLE. EXPENSES $ 3,640. GRANTS $ 2,948. REVENUE $ 0. INFORMATICS - THE GOAL IS TO PROMOTE THE USE AND DEVELOPMENT OF INFORMATICS IN AN INTEGRATIVE APPROACH TOWARDS THE UNDERSTANDING OF HUMAN BIOLOGICAL AND DISEASE. THIS PROGRAM SUPPORTS YOUNG SCIENTISTS WITH STIPEND AND RESEARCH SUPPORT. EXPENSES $ 38,584. GRANTS $ 31,250. REVENUE $ 0. PHARMACOLOGY/TOXICOLOGY AWARDS SUPPORT CAREER DEVELOPMENT ACTIVITIES OF SCIENTISTS PREPARED TO ENGAGE IN RESEARCH THAT INTEGRATES INFORMATION ON MOLECULAR OR CELLULAR MECHANISMS OF ACTION WITH INFORMATION ON THE EFFECTS OF AN AGENT OBSERVED IN AN INTACT ORGANISM. EXPENSES $ 61,735. GRANTS $ 50,000. REVENUE $ 0. OTHER PROGRAMS EXPENSES $ 246,308. GRANTS $ 12,000. REVENUE $ 0. |
| FORM 990, PART VI, SECTION A, LINE 7A: | THE CHIEF OPERATING OFFICER OF THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA), A SECTION 501(C)(6) TRADE ASSOCIATION THAT HAS A HISTORIC AND CONTINUING RELATIONSHIP WITH THE FOUNDATION, IS AN EX-OFFICIO MEMBER OF THE FOUNDATION'S BOARD OF DIRECTORS. FOUNDATION DIRECTORS MUST BE RESEARCH AND DEVELOPMENT EXECUTIVES OR CHIEF MEDICAL OFFICERS OF COMPANIES THAT ARE MEMBERS OF PHRMA, BUT ARE ELECTED BY THE FOUNDATION BOARD ITSELF. |
| FORM 990, PART VI, SECTION B, LINE 11B: | THE FOUNDATION FORM 990 IS PREPARED BY BDO USA LLP, CPAS, AND REVIEWED INTERNALLY BY KEY FINANCIAL MANAGEMENT AND THE FOUNDATION'S PRESIDENT. A COPY OF THE 990 IS PROVIDED TO THE BOARD OF DIRECTORS TO REVIEW PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C: | ALL DIRECTORS, OFFICERS AND KEY EMPLOYEES OF THE FOUNDATION MUST REPORT POTENTIAL AND ACTUAL CONFLICTS AS THEY ARISE. IN ADDITION, THEY ARE REQUIRED TO SIGN AN ANNUAL CONFLICT OF INTEREST DISCLOSURE STATEMENT. WHEN A POTENTIAL CONFLICT OF INTEREST IS DISCLOSED TO, OR OTHERWISE COMES TO THE ATTENTION OF, THE PRESIDENT, THE CHAIR OF THE BOARD OR A NON-AFFECTED DIRECTOR, HE OR SHE SHALL CONSIDER ALL THE RELEVANT CIRCUMSTANCES AND SHALL DETERMINE WHETHER THE ARRANGEMENT IS POTENTIALLY HARMFUL TO THE BEST INTERESTS OF THE FOUNDATION. IF THE ARRANGEMENT IS FOUND NOT TO BE HARMFUL, THEN THE ARRANGEMENT MAY BE AUTHORIZED OR APPROVED; OTHERWISE, THE DIRECTOR, OFFICER OR KEY EMPLOYEE WHO IS INVOLVED OR EXPECTS TO BE INVOLVED IN THE ARRANGEMENT SHALL BE NOTIFIED THAT THE ARRANGEMENT IS NOT AUTHORIZED OR APPROVED AND, IF ALREADY IN EXISTENCE, SHOULD BE TERMINATED. THE PRESIDENT SHALL AUTHORIZE OR APPROVE AN ARRANGEMENT ONLY AFTER CONSULTING WITH THE CHAIR OF THE BOARD. THE CHAIR OF THE BOARD SHALL AUTHORIZE OR APPROVE AN ARRANGEMENT ONLY UPON A VOTE OF A MAJORITY OF UNINVOLVED DIRECTORS. |
| FORM 990, PART VI, SECTION B, LINE 15: | MERIT RAISES AND BONUSES ARE DETERMINED IN ACCORDANCE WITH PHRMA POLICY BASED ON STAFF EVALUATIONS, AND RECOMMENDATIONS ARE FORWARDED TO THE PRESIDENT FOR REVIEW. OVERALL PERFORMANCE OF THE PRESIDENT OF THE FOUNDATION, INCLUDING MERIT RAISES AND BONUSES, IS ALSO DETERMINED IN ACCORDANCE WITH PHRMA POLICY BASED ON STAFF EVALUATIONS BY THE EX-OFFICIO MEMBER OF THE FOUNDATION BOARD. THIS EVALUATION IS FORWARDED AS ARE RECOMMENDATION TO THE CHAIRMAN AND VICE CHAIR OF THE FOUNDATION BOARD FOR FINAL APPROVAL OF THE PRESIDENT'S PERFORMANCE, INCLUDING COMPENSATION/BONUS. |
| FORM 990, PART VI, SECTION C, LINE 19: | THE FOUNDATION DOES NOT MAKE ITS GOVERNING DOCUMENTS OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. |
| FORM 990, PART XI, LINE 9: | GRANT REFUNDS $20,111 |
| FORM 990, PART XII, LINE 2C: | THE AUDIT OVERSIGHT PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. |